Nanocarrier-based drug delivery systems: enhancing targeted therapy in oncology
Registered Pharmacist and Public Health Specialist, Ministry of Health Malaysia.
Research Article
International Journal of Scholarly Research in Life Sciences, 2025, 03(01), 001–011.
Article DOI: 10.56781/ijsrls.2025.3.1.0021
Publication history:
Received on 04 April 2025; revised on 27 May 2025; accepted on 29 May 2025
Abstract:
The field of drug delivery has shown promise through Nanocarrier-based drug delivery systems (NDDS) by making targeted cancer therapy more precise with effective drug delivery methods. Therapeutic agents get encapsulated within nanoparticles through these systems, improving bioavailability while permitting controlled release capabilities and tumor cell-specific targeting effects that reduce harm to healthy tissue. Recent developments in NDDS prioritize creating better carrier systems using liposomes, dendrimers, and polymeric nanoparticles to enhance drug accumulation in tumor areas. Therapeutic performance has benefited significantly from implementing targeted mechanisms that use ligand-receptor connections and enhanced permeability and retention (EPR) effect. The research analyzes modern developments of NDDS in the oncology medical field while assessing its transformative influence on future cancer therapy methods. The assessment incorporates extensive clinical trial and experimental study research to evaluate these systems regarding their toxicity-reducing properties and drug-delivery optimization and survival rate enhancements for personalized cancer therapy.
Keywords:
Nanocarrier; Drug delivery systems; Targeted therapy; Oncology
Full text article in PDF:
Copyright information:
Copyright © 2025 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0